Pharmacotherapy for Erectile Dysfunction in 2021 and Beyond.

Area of Science:

• Urology
• Pharmacology
• Men's Health

Background:

• Erectile dysfunction (ED) is a prevalent urologic condition impacting men across all age groups.
• The prevalence of ED increases with age.
• The discovery of the nitric oxide pathway revolutionized ED treatment options.

Purpose of the Study:

• To review the primary pharmacologic treatments for erectile dysfunction.
• To provide an overview of current therapeutic strategies for ED.

Main Methods:

• Literature review of pharmacologic treatments for ED.
• Categorization of treatments into OTC/herbal supplements, PDE5 inhibitors, intraurethral suppositories (MUSE), and intracorporal injections (ICI).

Main Results:

• Multiple pharmacologic options exist for managing ED.
• Key treatments include phosphodiesterase type V inhibitors (PDE5I), MUSE, and ICI.
• Over-the-counter and herbal supplements are also discussed.

Conclusions:

• Pharmacologic interventions offer effective management for erectile dysfunction.
• A range of treatment modalities are available to address ED.
• Understanding these options is crucial for patient care.